(Q70017795)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3949927%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

title

Separation of spironolactone and its biologically active sulfur-containing metabolites by high-performance liquid chromatography (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3949927%20AND%20SRC:MED&resulttype=core&format=json

high-performance liquid chromatography

7 October 2019

main subject

1 reference

J H Sherry

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3949927%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

J P O'Donnell

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3949927%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

H D Colby

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3949927%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

publication date

1 January 1986

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3949927%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

volume

374

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3949927%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3949927%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

page(s)

183-190

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3949927%20AND%20SRC:MED&resulttype=core&format=json

Blocking the renal electrolyte effects of mineralocorticoids with an orally active steroidal spirolactone

7 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2983269-7

7 January 2021

Metabolism of digitoxin in man and its modification by spironolactone

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2983269-7

7 January 2021

Stimulation of liver microsomal drug metabolism in male and female mice by spironolactone and aldadiene

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2983269-7

7 January 2021

On the mechanism of the inhibitory action of the spirolactone SC 9376 (aldadiene) on the production of corticosteroids in rat adrenals in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2983269-7

7 January 2021

Spironolactone and cytochrome P-450: Impairment of steroid hydroxylation in the adrenal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2983269-7

7 January 2021

Spironolactone and cytochrome P-450: Impairment of steroid 21-hydroxylation in the adrenal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2983269-7

7 January 2021

Reduced aldosterone secretion during spironolactone treatment in primary aldosteronism: report of a case

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2983269-7

7 January 2021

Relation of Canrenone to the Actions of Spironolactone on Adrenal Cytochrome P-450-Dependent Enzymes*

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2983269-7

7 January 2021

Spironolactone: Disposition, Metabolism, Pharmacodynamics, and Bioavailability

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2983269-7

7 January 2021

Spironolactone: Diversity in Metabolic Pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2983269-7

7 January 2021

Antagonism of fludrocortisone by spironolactone and canrenone

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2983269-7

7 January 2021

Spironolactone and potassium canrenoate in normal man

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2983269-7

7 January 2021

Effect of spironolactone and its main metabolite canrenone on the renin-angiotensin-aldosterone-system during long-term treatment in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2983269-7

7 January 2021

Pharmacokinetics of spironolactone after a single dose: evaluation of the true canrenone serum concentrations during 24 hours

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2983269-7

7 January 2021

Pharmacokinetics of canrenone and metabolites after base hydrolysis following single and multiple dose oral administration of spironolactone

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2983269-7

7 January 2021

Molecular modifications of anti-aldosterone compounds: effects on affinity of spirolactones for renal aldosterone receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2983269-7

7 January 2021

Agonist and antimineralocorticoid activities of spirolactones

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2983269-7

7 January 2021

High-performance liquid chromatographic determination of canrenone, a major metabolite of spironolactone, in body fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2983269-7

7 January 2021

10.1016/S0378-4347(00)83269-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3949927%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

1 reference